Clinical Trial

A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the PK of a tablet formulation of ABBV-722 under fasted conditions and the effect of food on its bioavailability after administration of single doses
Protocol Amendment History 1 change
critical Trial completed 2026-04-25
Trial Details
NCT Number NCT07361367
Lead Sponsor AbbVie
Conditions Healthy Volunteers
Enrollment 11 participants
Start Date 2026-01-15
Primary Completion 2026-03-23 (estimated)
Study Completion 2026-03-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-24